---
title: "Stryker Q2 Adjusted EPS USD 3.69 Vs. IBES Estimate USD 3.49"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294408356.md"
datetime: "2026-07-30T20:06:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294408356.md)
  - [en](https://longbridge.com/en/news/294408356.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294408356.md)
---

# Stryker Q2 Adjusted EPS USD 3.69 Vs. IBES Estimate USD 3.49

Jul 30 (Reuters) - Stryker Q2 net sales USD 6,600 million vs. IBES estimate USD 6,579 million. \* Q2 EPS USD 3.3 \* outlook FY adjusted EPS USD 14.95-15.1 vs. IBES estimate USD 15 \* outlook FY organic net sales growth 8.3-9.3%

### Related Stocks

- [SYK.US](https://longbridge.com/en/quote/SYK.US.md)

## Related News & Research

- [Stryker Q2 adjusted EPS beats estimates, narrows 2026 outlook](https://longbridge.com/en/news/294410030.md)
- [15,653 Shares in Stryker Corporation $SYK Bought by First Nebraska Trust Co](https://longbridge.com/en/news/294600116.md)
- [Stryker: Analyst Sees Share Weakness as a Chance to Buy into a Durable High-Growth Medtech Leader](https://longbridge.com/en/news/294604604.md)
- [Stryker (NYSE:SYK) Announces Quarterly Earnings Results](https://longbridge.com/en/news/294418968.md)
- [Stryker Corp Stock (SYK) Moved Up by 4.41% on Aug 3: What Investors Need To Know](https://longbridge.com/en/news/294728669.md)